产品名称
抗-链球菌标签单克隆抗体 小鼠抗, clone GT517, affinity isolated antibody
biological source
mouse
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
GT517, monoclonal
form
buffered aqueous solution
concentration
1mg/mL
technique(s)
indirect immunofluorescence: suitable
western blot: 1000-10000
isotype
IgG1
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Quality Level
Application
建议的起始稀释度如下：ICC/IF：1：100-1：1000，蛋白质印迹：1:1000-1:10000.尚未在其他应用中测试。最佳工作稀释度应由最终用户通过实验确定。
Biochem/physiol Actions
strep-标签/strep-标签II（改进版本）具有与任何目标蛋白或肽结合的能力。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Features and Benefits
完放心地使用我们的抗体。如果抗体在您的申请的研究中不起作用，我们将全额退款或安排替代抗体。了解更多信息。
General description
strep-标签/strep-标签II（改进版本）由八个氨基酸序列（Trp-Ser-His-Pro-Gln-Phe-Glu-Lys）组成。
Immunogen
用于生成该抗体的免疫原对应于链球菌标签
Other Notes
纯化方法：Protein G亲和纯化
Physical form
磷酸盐缓冲液，未加保护剂。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
此项目有
The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins.
Schmidt TG and Skerra A
Nature Protocols, 2(6), 1528-1528 (2007)
Zhaofeng Yan et al.
Nature communications, 11(1), 241-241 (2020-01-15)
A major component of bacterial biofilms is curli amyloid fibrils secreted by the curli biogenesis system. Understanding the curli biogenesis mechanism is critical for developing therapeutic agents for biofilm-related infections. Here we report a systematic study of the curli biogenesis
The Strep-tag system for one-step affinity purification of proteins from mammalian cell culture.
Schmidt T and Skerra A
Methods in Molecular Biology, 1286, 83-95 (2015)
Timothy A Bates et al.
Cell reports, 34(7), 108737-108737 (2021-02-06)
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, there remain unanswered questions regarding the nature and significance of the humoral immune response toward other coronavirus infections. Here, we investigate the cross-reactivity of antibodies raised against the first severe acute respiratory
Timothy A Bates et al.
bioRxiv : the preprint server for biology (2020-08-09)
There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持